The biotech sector is experiencing a downturn due to drug failures, impacting companies like Amgen and Eli Lilly.

1 report, 1 independent Updated Sep 8

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Amgen Eli Lilly and Company

Keep exploring

Part of

Amgen and Eli Lilly offer treatments for thyroid eye disease, with Lilly's pipeline requiring regulatory approval. All 1 developments

The entities involved

Amgen
American multinational biopharmaceutical company
- Amgen, City of Hope, and the California Community Foundation are involved in a life sciences and bioscience economic summit held in Downtown Los Angeles.Mon 12:08
- Geode Capital Management increased its stake in Amgen stock and filed the disclosure with the SEC.Mon 02:05
Eli Lilly and Company
American pharmaceutical company
- ExxonMobil, Berkshire Hathaway, and Eli Lilly are top holdings in the Avantis ETF.Mon 17:18
- The FDA approved Olumiant for pediatric indications on September 1, 2026.Mon 05:59

Related events

FDA approval clears the path for drug market entry, driving future regulatory focus for major pharmaceutical companies.Aug 18

Coverage

Newest first; wire copies grouped

Sep 8investors.com